SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
QuidelOrtho Corporation QDEL recently announced that its TriageTrue High-Sensitivity Troponin I (hsTnl) Test on the Quidel Triage MeterPro had been approved for use in Canada by Health Canada. Per the ...
QuidelOrtho is recalling thousands of blood tests used to help quickly diagnose myocardial infarctions and other heart conditions. The company began recalling certain lots of the Quidel Triage Cardiac ...
Credit: Medical Images. This recall has been classified as a Class I recall. Quidel Cardiovascular Inc is recalling the Quidel Triage Cardiac Panel because of the potential risk for false negative ...
Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results